Sandbox: manpreet kaur: Difference between revisions

Revision as of 20:08, 27 October 2017

Salvage therapies for Helicobacter pylori infection
Regimen	Drugs(doses)	Dosing frequency	Duration(days)	FDA approval
Bismuth quadruple	PPI(standard dose) Bismuth subciitrate(120-300mg or sub salicylate(300mg) Tetracycline(500mg) Metronidazole(500mg)	BID QID QID TID or QID	14	NO(a)
Levofloxacin triple	PPI(standard dose) Levofloxacin (500mg) Amox(1gm)	BID QD BID	14	NO
Concomitant	PPI(standard dose) Clarithromycin(500mg) Amoxicillin(1gm) Nitroimidazole(500mg)	BID BID BID BID or TID	10-14	NO
Rifabutin triple	PPI(standard dose) Rifabutin(300mg) Amox(1gm)	BID QD BID	10	NO
High-dose dual	PPI(standard to double dose) Amox(1gm TID or 750mg QID)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]

References should be cited for the material that you have put on your page. Type in {{reflist|2}}.This will generate your references in small font, in two columns, with links to the original article and abstract.
For information on how to add references into your page, click here.

@@ Line 60: / Line 60: @@
 * Rifabutin(300mg)
 * Amox(1gm)
+|BID
+QD
+BID
+|10
+|NO
+|-
+|High-dose dual
+|
+* PPI(standard to double dose)
+* Amox(1gm TID or 750mg QID)
 |
 |